We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
PET imaging for tau visualization in the brain
Product News

PET imaging for tau visualization in the brain

PET imaging for tau visualization in the brain
Product News

PET imaging for tau visualization in the brain


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "PET imaging for tau visualization in the brain"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Tau is an excellent biomarker and a major pharmaceutic target for Alzheimer’s disease (AD) given its contribution to neurodegeneration.


Aberrant accumulation and aggregation of phosphorylated Tau (p-Tau), and formation of neurofibrillary tangles (NFT) composed of hyperphosphorylated Tau, are a prominent characteristic of AD. Tau pathology has been linked to both sporadic and familial forms of AD; with over 40 different mutations found in the gene that encodes this protein [microtubule-associated protein tau (MAPT) gene].


The use of imaging agents that can efficiently cross the blood-brain barrier (BBB) and detect pathological forms of Tau with high specificity will allow specific monitoring of Tau species, and elucidating their temporal expression, topographical distribution and spatial relationship relative to disease pathology and clinical changes that occur during disease progression.


Non-invasive assessment of Tau deposition and correlation with the extent of neurodegeneration will provide new insights into tau pathology in the human brain.


BioLegend
Refer to BioLegend’s Tau homepage to learn more about Tau protein and a comprehensive list of Tau antibodies and recombinant proteins


BioLegend


Advertisement